专题报道

2025年全国疟疾流行病学特征分析

  • 张丽 ,
  • 夏志贵 ,
  • 李石柱
展开
  • 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心), 传染病溯源预警与智能决策全国重点实验室,国家卫生健康委员会寄生虫病原与媒介生物学重点实验室,世界卫生组织热带病合作中心,科技部国家级热带病国际联合研究中心, 上海 200025
张丽,女,硕士,副研究员,从事寄生虫病研究。E-mail:zhangli@nipd.chinacdc.cn
作者贡献

张丽负责数据审核、分析并撰写论文,夏志贵、李石柱负责论文审核。

* 夏志贵,男,硕士,研究员,从事疟疾流行病学及控制与消除研究。E-mail:xiazg@nipd.chinacdc.cn

收稿日期: 2026-03-18

  修回日期: 2026-04-16

  网络出版日期: 2026-04-21

Epidemiological characteristics of malaria in China, 2025

  • ZHANG Li ,
  • XIA Zhigui ,
  • LI Shizhu
Expand
  • National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention; Chinese Center for Tropical Diseases Research; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases; NHC Key Laboratory of Parasite and Vector Biology; WHO Collaborating Centre for Tropical Diseases; National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China

Received date: 2026-03-18

  Revised date: 2026-04-16

  Online published: 2026-04-21

摘要

收集监测报告管理系统中2025年全国31个省(直辖市、自治区,未包括台湾、香港和澳门地区)和新疆生产建设兵团的《疟疾流行病学个案调查表》,对疟疾病例流行病学特征进行统计分析。2025年全国报告疟疾病例4 314例,较2017年(2 861例)、2021年(799例)、2024年(3 157例)分别增加了50.8%、439.9%、36.6%;死亡病例11例,较2024年(15例)减少4例。恶性疟2 829例(占65.6%,2 829/4 314),间日疟963例(占22.3%,963/4 314),卵形疟372例(占8.6%,372/4 314),三日疟103例(占2.4%,103/4 314),混合感染47例(占1.1%,47/43 14)。境外输入性病例4 308例,非蚊传疟疾病例(输血感染)5例,长潜伏期再燃病例1例(三日疟)。除西藏自治区外,其余30个省份和新疆生产建设兵团均有疟疾病例报告,病例数居前5位的省份依次为云南(678例)、广东(359例)、河南(354例)、湖南(338例)和山东(307例),累计报告2 036例(占47.2%,2 036/4 314)。男女性别比为12.8 ∶ 1,30~39岁年龄组的病例最多(占29.1%,1 255/4 314),出境/入境事由以务工为主(占71.6%,3 086/4 308)。有27个省份报告危重症病例131例(占3.0%,131/4 314),较2024年(112例)增加了17.0%。近4年,我国疟疾疫情呈现持续上升趋势,数千例境外输入性病例给防止输入再传播工作带来压力和挑战。

本文引用格式

张丽 , 夏志贵 , 李石柱 . 2025年全国疟疾流行病学特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2026 , 44(2) : 153 -157 . DOI: 10.12140/j.issn.1000-7423.2026.02.001

Abstract

Malaria case investigation forms in 31 provinces/municipalities/autonomous regions (excluding Taiwan, Hongkong, Macao) and the Xinjiang Production and Construction Corps aross China in 2025 were collected from the National Notifiable Infectious Diseases Reporting Information System, and the epidemiological characteristic of malaria cases were statistically analyzed. A total of 4 314 malaria cases were reported in China in 2025, which increased by 50.8%, 439.9%, and 36.6% relative to in 2017 (2 861), 2021 (799) and 2024 (3 157), respectively, and 11 deaths were reported in 2025, which reduced by four as compared to in 2024 (15 deaths). Of all reported malaria cases, there were 2 829 Plasmodium falciparum malaria cases (65.6%, 2 829/4 314), 963 P. vivax malaria cases (22.3%. 963/4 314), 372 P. ovale malaria cases (8.6%, 372/4 314), 103 P. malariae malaria cases (2.4%,103/4 314), and 47 cases with mixed infections (1.1%, 47/4 314), and there were 4 308 imported cases, 5 non-mosquito-borne malaria cases (transfusion-transmitted infection), and one recrudescent case with a long incubation period (P. malariae malaria). Malaria cases were reported in 30 provinces and the Xinjiang Production and Construction Corps, with the exception of Xizang Autonomous Region, with Yunnan Province (678 cases), Guangdong Province (359 cases), Henan Province (354 cases), Hunan Province (338 cases), and Shandong Province (307 cases) as the five most seriously affected provinces, accounting for 47.2% (2 036/4 314) of totally reported malaria cases. The ratio of male to female cases was 12.8 ∶ 1, and patients at ages of 30 to 39 years accounted for the largest proportion of cases (29.1%, 1 255/4 314). The most common reason for exit and entry was labor (71.6%, 3 086/4 308). A total of 131 critically ill malaria cases were reported across 27 provinces in 2025 (3.0%, 131/4 314), which increased by 17.0% relative to in 2024 (112 cases). Malaria epidemic has risen for four consecutive years in China, and thousands of imported malaria cases have posed substantial pressure and challenges to prevention of re-establishment of imported malaria.

参考文献

[1] 张丽, 丰俊, 张少森, 等. 2017年全国消除疟疾进展及疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(3): 201-209.
  Zhang L, Feng J, Zhang SS, et al. The progress of national malaria elimination and epidemiological characteristics of malaria in China in 2017[J]. Chin J Parasitol Parasit Dis, 2018, 36(3): 201-209. (in Chinese)
[2] 张丽, 丰俊, 张少森, 等. 2018年全国疟疾疫情特征及消除工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(3): 241-247.
  Zhang L, Feng J, Zhang SS, et al. Epidemiological characteristics of malaria and the progress towards its elimination in China in 2018[J]. Chin J Parasitol Parasit Dis, 2019, 37(3): 241-247. (in Chinese)
[3] 张丽, 丰俊, 夏志贵, 等. 2019年全国疟疾疫情特征分析及消除工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(2): 133-138.
  Zhang L, Feng J, Xia ZG, et al. Epidemiological characteristics of malaria and progress on its elimination in China in 2019[J]. Chin J Parasitol Parasit Dis, 2020, 38(2): 133-138. (in Chinese)
[4] 张丽, 丰俊, 涂宏, 等. 2020年全国疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(2): 195-199.
  Zhang L, Feng J, Tu H, et al. Malaria epidemiology in China in 2020[J]. Chin J Parasitol Parasit Dis, 2021, 39(2): 195-199. (in Chinese)
[5] 张丽, 易博禹, 夏志贵, 等. 2021年全国疟疾疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(2): 135-139.
  Zhang L, Yi BY, Xia ZG, et al. Epidemiological characteristics of malaria in China, 2021[J]. Chin J Parasitol Parasit Dis, 2022, 40 (2): 135-139. (in Chinese)
[6] 张丽, 易博禹, 尹建海, 等. 2022年全国疟疾疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 137-141.
  Zhang L, Yi BY, Yin JH, et al. Epidemiological characteristics of malaria in China, 2022[J]. Chin J Parasitol Parasit Dis, 2023, 41 (2): 137-141. (in Chinese)
[7] 张丽, 夏志贵. 2023年全国疟疾疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(2): 135-139.
  Zhang L, Xia ZG. Epidemiological characteristics of malaria in China, 2023[J]. Chin J Parasitol Parasit Dis, 2024, 42(2): 135-139. (in Chinese)
[8] 张丽, 夏志贵, 李石柱. 2024年全国疟疾疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(2): 1-5.
  Zhang L, Xia ZG, Li SZ. Epidemiological characteristics of malaria in China, 2024[J]. Chin J Parasitol Parasit Dis, 2025, 43(2): 1-5. (in Chinese)
[9] 中华人民共和国商务部. 2025年我国对外劳务合作业务简明统计[EB/OL]. (2026-01-29)[2026-03-04]. https://www.mofcom.gov.cn/zfxxgk/fdzdgknr/ztfl/tjsj/gwjjhztj/art/2026/art_0537794a-3cd347c087c3f4a877f4fb8a.html.
  Minstry of Commerce of the People’s Republic of China. Brief statistics on China’s overseas labor cooperation business in 2025[EB/OL]. (2026-01-29)[2026-03-04]. https://www.mofcom.gov.cn/zfxxgk/fdzdgknr/ztfl/tjsj/gwjjhztj/art/2026/art_0537794a-3cd347c087c3f4a877f4fb8a.html. (in Chinese)
[10] World Health Organization. World malaria report 2025[M]. Geneva: WHO Press, 2025: 17.
[11] 林祖锐, 邵宗体, 夏志贵. 云南中缅边境地区防止疟疾输入再传播的成效、 经验与挑战[J]. 中国热带医学, 2026, 26(1): 41-44.
  Lin ZR, Shao ZT, Xia ZG. Achievements, experience and challenges in preventing importation and re-transmission of malaria in the China-Myanmar border area of Yunnan Province[J]. China Trop Med, 2026, 26(1): 41-44. (in Chinese)
[12] 王新宇, 张文宏. 中国消除疟疾流行后如何加强临床医生疟疾的诊治能力[J]. 临床内科杂志, 2022, 39(4): 217-218.
  Wang XY, Zhang WH. How to strengthen the clinicia’s ability to diagnose and treat malaria after eliminating malaria epidemic in China[J]. J Clin Intern Med, 2022, 39(4): 217-218. (in Chinese)
[13] 林红, 朱绍汶, 陈妍, 等. 我国输血传播疟疾的现状与挑战[J]. 中国输血杂志, 2019, 32(1): 93-96.
  Lin H, Zhu SW, Chen Y, et al. Status review and challenges of transfusion transmitted malaria in China[J]. Chin J Blood Transfus, 2019, 32(1): 93-96. (in Chinese)
文章导航

/

〈 〉